Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy

NCT07629635 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Migraine Disease
Patent Foramen Ovale

Interventions

DRUG: Prasugrel 5mg
DEVICE: Transcatheter Closure of Patent Foramen Ovale

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]